Fumiya Wada

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Durable platelet response and immature platelet indices following sequential efgartigimod and eltrombopag therapy in a patient with refractory ITP.

Durable platelet response and immature platelet indices following sequential efgartigimod and eltrombopag therapy in a patient with refractory ITP.

Journal: Platelets
Published: July 28, 2026

Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.

Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.

Journal: British journal of haematology
Published: February 05, 2026

Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation.

Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation.

Journal: EJHaem
Published: September 28, 2025

Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease.

Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease.

Journal: Transplantation and cellular therapy
Published: October 16, 2024

Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation.

Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation.

Journal: Blood advances
Published: September 27, 2024

Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation.

Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation.

Journal: Leukemia
Published: August 23, 2024

Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation.

Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation.

Journal: Cell transplantation
Published: August 30, 2023

Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation.

Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: May 28, 2023

Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.

Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.

Journal: American journal of hematology
Published: April 12, 2023

An adult case of refractory autoimmune neutropenia after liver transplantation.

An adult case of refractory autoimmune neutropenia after liver transplantation.

Journal: International journal of hematology
Published: October 05, 2022

Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation.

Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation.

Journal: Transplantation and cellular therapy
Published: August 20, 2022

T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy.

T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy.

Journal: Scientific reports
Published: July 02, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026